Thus, additional functional studies are needed to further elucidate the oncogenic impact of DCLK1 in promoting the malignant potential of cancer cells and its role in the adverse prognosis noted in HNSCC. This evidence concerns the gene DCLK1 and head and neck squamous cell carcinoma.